Fernando García López

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study

Pilar Díz, Alfonso Otero-González, María Xosé Rodríguez‐Álvarez et al. · BMC Endocrine Disorders · 2013 · 527 citations · Full text

Prevalence of chronic renal disease in Spain: results of the EPIRCE study.

A Otero, de Francisco A, Fernando García López · PubMed · 2010 · 350 citations

Glomerulonephritis, Hemodialysis, Urology +13

Emergency department point-of-care ultrasound in out-of-hospital and in-ED cardiac arrest

Romolo Gaspari, Anthony J. Weekes, Srikar Adhikari et al. · Resuscitation · 2016 · 265 citations

Medical Ultrasound, Emergency Care, Medicine +8